Skip to main content
Top
Published in: International Urology and Nephrology 3/2013

01-06-2013 | Urology - Original Paper

The number of nodes removed as well as the template of the dissection is independently correlated to cancer-specific survival after radical cystectomy for muscle-invasive bladder cancer

Authors: Eugenio Brunocilla, Remigio Pernetti, Riccardo Schiavina, Marco Borghesi, Valerio Vagnoni, Giovanni Christian Rocca, Filippo Borgatti, Sergio Concetti, Giuseppe Martorana

Published in: International Urology and Nephrology | Issue 3/2013

Login to get access

Abstract

Purpose

To assess the impact of the number of lymph nodes removed and of the template of dissection during radical cystectomy for bladder cancer on patients’ survival rates.

Materials and methods

We evaluated 282 consecutive patients who underwent radical cystectomy for muscle-invasive or high-grade superficial bladder cancer between 1995 and 2011. Exclusion criteria were incomplete follow-up data and neo-adjuvant or adjuvant treatments. Patients were divided into groups according to the most informative cut-point of number of lymph nodes retrieved and of the template of dissection. The cancer-specific survival rates were estimated by the Kaplan–Meier method. The univariate and multivariable forward-stepwise Cox proportional hazards regression were applied to analyze the survival outcomes.

Results

The mean (SD) follow-up was 59.2 ± 44.3 months, and the mean (SD) age of the entire cohort population was 68.3 ± 8.3 years. The cancer-specific survival rates were 58.7 and 47.7 % at 5 and 10 years, respectively. Considering both node-positive and node-negative patients, those with at least 14 LNs removed and those submitted to extended or super-extended PLND experienced significantly higher cancer-specific survival at both univariate and multivariable analysis.

Conclusions

Patients undergoing a more extended pelvic lymph node dissection, both in terms of number of LN removed and in terms of template of dissection, will experience a better cancer-specific survival. Our data support a potential role of lymphadenectomy on cancer outcome.
Literature
1.
go back to reference Kondo T, Tanabe K (2012) Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract. Int J Urol 19(8):710–721PubMedCrossRef Kondo T, Tanabe K (2012) Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract. Int J Urol 19(8):710–721PubMedCrossRef
2.
go back to reference Herr HW, Bochner BH, Dalbagni G et al (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295–1298PubMedCrossRef Herr HW, Bochner BH, Dalbagni G et al (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295–1298PubMedCrossRef
3.
go back to reference Brunocilla E, Pernetti R, Martorana G (2011) The role of pelvic lymph node dissection during radical cystectomy for bladder cancer. Anticancer Res 31(1):271–275PubMed Brunocilla E, Pernetti R, Martorana G (2011) The role of pelvic lymph node dissection during radical cystectomy for bladder cancer. Anticancer Res 31(1):271–275PubMed
4.
go back to reference Jensen TK, Holt P, Gerke O et al (2011) Preoperative lymph node staging of invasive urothelial bladder cancer with 18F- fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Scand J Urol Nephrol 45:122–128PubMedCrossRef Jensen TK, Holt P, Gerke O et al (2011) Preoperative lymph node staging of invasive urothelial bladder cancer with 18F- fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Scand J Urol Nephrol 45:122–128PubMedCrossRef
5.
go back to reference Maurer T, Souvatzoglou M, Kübler H et al (2012) Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy. Eur Urol 61(5):1031–1038PubMedCrossRef Maurer T, Souvatzoglou M, Kübler H et al (2012) Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy. Eur Urol 61(5):1031–1038PubMedCrossRef
6.
go back to reference Leissner J, Ghoneim MA, bol-Enein H et al (2004) Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171:139–144PubMedCrossRef Leissner J, Ghoneim MA, bol-Enein H et al (2004) Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171:139–144PubMedCrossRef
7.
go back to reference Wiesner C, Salzer A, Thomas C et al (2009) Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. BJU Int 104:331–335PubMedCrossRef Wiesner C, Salzer A, Thomas C et al (2009) Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. BJU Int 104:331–335PubMedCrossRef
8.
go back to reference Holmer M, Bendahl PO, Davidsson T et al (2009) Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference? World J Urol 27:521–526PubMedCrossRef Holmer M, Bendahl PO, Davidsson T et al (2009) Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference? World J Urol 27:521–526PubMedCrossRef
9.
go back to reference Dhar NB, Klein EA, Reuther AM et al (2008) Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179:873–878PubMedCrossRef Dhar NB, Klein EA, Reuther AM et al (2008) Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179:873–878PubMedCrossRef
10.
go back to reference bol-Enein H, Tilki D, Mosbah A et al (2011) Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. Eur Urol 60:572–577CrossRef bol-Enein H, Tilki D, Mosbah A et al (2011) Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. Eur Urol 60:572–577CrossRef
11.
go back to reference Wright JL, Lin DW, Porter MP (2008) The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer 112:2401–2408PubMedCrossRef Wright JL, Lin DW, Porter MP (2008) The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer 112:2401–2408PubMedCrossRef
12.
go back to reference Honma I, Masumori N, Sato E et al (2006) Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer–analysis of role of pelvic lymph node dissection. Urology 68:543–548PubMedCrossRef Honma I, Masumori N, Sato E et al (2006) Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer–analysis of role of pelvic lymph node dissection. Urology 68:543–548PubMedCrossRef
13.
go back to reference Stenzl A, Cowan NC, De SM et al (2011) Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guide- lines. Eur Urol 59:1009–1018PubMedCrossRef Stenzl A, Cowan NC, De SM et al (2011) Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guide- lines. Eur Urol 59:1009–1018PubMedCrossRef
14.
go back to reference Svatek R, Zehnder P (2012) Role and extent of lymphadenectomy during radical cystectomy for invasive bladder cancer. Curr Urol Rep 13(2):115–121PubMedCrossRef Svatek R, Zehnder P (2012) Role and extent of lymphadenectomy during radical cystectomy for invasive bladder cancer. Curr Urol Rep 13(2):115–121PubMedCrossRef
16.
go back to reference Brunocilla E, Pernetti R, Martorana G (2011) The prognostic role of lymphovascular invasion in urothelial-cell carcinoma of upper and lower urinary tract. Anticancer Res 31(10):3503–3506PubMed Brunocilla E, Pernetti R, Martorana G (2011) The prognostic role of lymphovascular invasion in urothelial-cell carcinoma of upper and lower urinary tract. Anticancer Res 31(10):3503–3506PubMed
17.
go back to reference Palmieri F, Brunocilla E, Bertaccini A et al (2010) Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy. Anticancer Res 30:2973–2976PubMed Palmieri F, Brunocilla E, Bertaccini A et al (2010) Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy. Anticancer Res 30:2973–2976PubMed
18.
go back to reference Sobin LH, Gospodariwicz M, Wittekind C (eds) (2009) TNM classification of malignant tumors. UICC international union against cancer, 7th edn. Wiley, Hoboken, pp 262–265 Sobin LH, Gospodariwicz M, Wittekind C (eds) (2009) TNM classification of malignant tumors. UICC international union against cancer, 7th edn. Wiley, Hoboken, pp 262–265
19.
go back to reference Schiavina R, Borghesi M, Guidi M et al (2013) Perioperative complications and mortality after radical cystectomy when using a standardized reporting methodology. Clin Genitourin Cancer. doi:10.1016/j.clgc.2012.12.003 Schiavina R, Borghesi M, Guidi M et al (2013) Perioperative complications and mortality after radical cystectomy when using a standardized reporting methodology. Clin Genitourin Cancer. doi:10.​1016/​j.​clgc.​2012.​12.​003
20.
go back to reference Park J, Kim S, Jeong IG et al (2011) Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy? World J Urol 29(4):443–449PubMedCrossRef Park J, Kim S, Jeong IG et al (2011) Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy? World J Urol 29(4):443–449PubMedCrossRef
21.
go back to reference Zehnder P, Studer UE, Skinner EC et al (2011) Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 186(4):1261–1268PubMedCrossRef Zehnder P, Studer UE, Skinner EC et al (2011) Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 186(4):1261–1268PubMedCrossRef
22.
go back to reference Dorin RP, Daneshmand S, Eisenberg MS et al (2011) Lymph Node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol 60(5):946–952PubMedCrossRef Dorin RP, Daneshmand S, Eisenberg MS et al (2011) Lymph Node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol 60(5):946–952PubMedCrossRef
23.
go back to reference Stein JP, Penson DF, Cai J et al (2007) Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 177:876–881PubMedCrossRef Stein JP, Penson DF, Cai J et al (2007) Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 177:876–881PubMedCrossRef
24.
go back to reference Jensen JB, Ulhøi BP, Jensen KM (2012) Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival. Int J Urol 19(1):39–47PubMedCrossRef Jensen JB, Ulhøi BP, Jensen KM (2012) Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival. Int J Urol 19(1):39–47PubMedCrossRef
25.
go back to reference Morgan TM, Kaffenberger SD, Cookson MS (2012) Surgical and chemotherapeutic management of regional lymph nodes in bladder cancer. J Urol 188(4):1081–1088PubMedCrossRef Morgan TM, Kaffenberger SD, Cookson MS (2012) Surgical and chemotherapeutic management of regional lymph nodes in bladder cancer. J Urol 188(4):1081–1088PubMedCrossRef
26.
go back to reference Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604–1608PubMedCrossRef Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604–1608PubMedCrossRef
Metadata
Title
The number of nodes removed as well as the template of the dissection is independently correlated to cancer-specific survival after radical cystectomy for muscle-invasive bladder cancer
Authors
Eugenio Brunocilla
Remigio Pernetti
Riccardo Schiavina
Marco Borghesi
Valerio Vagnoni
Giovanni Christian Rocca
Filippo Borgatti
Sergio Concetti
Giuseppe Martorana
Publication date
01-06-2013
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2013
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-013-0461-8

Other articles of this Issue 3/2013

International Urology and Nephrology 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.